Building AI Systems for Global Health
Safer Futures with
Digital Innovation & Collective Wisdom
Tackling Global Healthcare Challenges through
Medical DX and Generative AI
NEWS
NEWS & UPDATES
Stay informed with the latest news, insights, and announcements from CartaNova.
NEWS
NEWS & UPDATES
Stay informed with the latest news, insights, and announcements from CartaNova.
ABOUT
"Through medical digital transformation (DX) and collaboration with diverse communities,
we aim to build AI systems that predict, prevent, and contain infectious diseases,
creating a sustainable society where everyone can live with peace of mind."
We leverage generative AI and digital technologies to co-create new mechanisms for predicting, preventing, and containing infectious diseases together with society.
By preparing for emerging and re-emerging infections, antimicrobial resistance (AMR), and future pandemics, we collaborate with healthcare professionals, researchers, governments, and citizens to realize a sustainable and resilient society.
Kazuaki Jindai • CEO & Co-founder of CartaNova
PROJECTS
Proven Impact & Results
Explore Projects that reflect our AI expertise & real world impact
PROJECTS
Proven Impact & Results
Explore Projects that reflect our AI expertise & real world impact
PROJECT 1
PROJECT 2
PROJECT 3
01
NovaID — AI System for Antimicrobial Resistance (AMR)
NovaID is an AI-driven system for antimicrobial resistance (AMR) surveillance and intelligent treatment recommendations. It integrates clinical, microbiological, and epidemiological data to support evidence-based decision-making. Developed in collaboration with international partners, NovaID aims to strengthen global health resilience against AMR.
PROJECT 1
PROJECT 2
PROJECT 3
01
NovaID — AI System for Antimicrobial Resistance (AMR)
NovaID is an AI-driven system for antimicrobial resistance (AMR) surveillance and intelligent treatment recommendations. It integrates clinical, microbiological, and epidemiological data to support evidence-based decision-making. Developed in collaboration with international partners, NovaID aims to strengthen global health resilience against AMR.
NovaID — Overview
NovaID is an AI-driven system designed to integrate infectious disease data, antimicrobial resistance (AMR) data, and clinical information to monitor resistance patterns and support treatment decision-making.
Core Capabilities
AMR Surveillance Intelligence
Connects data from hospitals, laboratories, and public institutions to automatically monitor regional and national resistance trends.
Analyzes resistance rates, infection patterns, and antimicrobial usage in real time.
AI-driven Treatment Recommendation
Suggests initial antimicrobial prescriptions based on infection site, pathogen, and patient condition.
Provides both local-layer recommendations (reflecting local resistance patterns) and core-layer recommendations (based on international standards).
Ontology-based Knowledge Model
Represents infectious diseases, pathogens, and antimicrobial data in a structured medical ontology framework.
Visualizes decision-making rationale in a human-understandable format.
Explainable AI (XAI) & Validation Layer
Transparently presents the rationale behind AI recommendations (e.g., resistance data, treatment success rates).
Incorporates expert validation and continuous feedback from clinicians.
WORK PARTS
Our Scope of Work
From data to decision — designing the foundations of AI
WORK PARTS
Our Scope of Work
From data to decision — designing the foundations of AI
Ontology-based Data Integration
Structuring clinical, microbiological, and epidemiological data into an intelligent knowledge framework that AI can understand and reason with — enabling deeper insights into infectious diseases.
01
Ontology-based Data Integration
Structuring clinical, microbiological, and epidemiological data into an intelligent knowledge framework that AI can understand and reason with — enabling deeper insights into infectious diseases.
01
Ontology-based Data Integration
Structuring clinical, microbiological, and epidemiological data into an intelligent knowledge framework that AI can understand and reason with — enabling deeper insights into infectious diseases.
01
AI System Infrastructure
Designing scalable and secure AI infrastructures that connect infection surveillance data, clinical workflows, and decision-making environments across institutions and regions.
02
AI System Infrastructure
Designing scalable and secure AI infrastructures that connect infection surveillance data, clinical workflows, and decision-making environments across institutions and regions.
02
AI System Infrastructure
Designing scalable and secure AI infrastructures that connect infection surveillance data, clinical workflows, and decision-making environments across institutions and regions.
02
AI System Development
Building AI systems specialized in infectious disease prediction, prevention, and control — transforming complex health data into actionable intelligence for clinicians and public health professionals.
03
AI System Development
Building AI systems specialized in infectious disease prediction, prevention, and control — transforming complex health data into actionable intelligence for clinicians and public health professionals.
03
AI System Development
Building AI systems specialized in infectious disease prediction, prevention, and control — transforming complex health data into actionable intelligence for clinicians and public health professionals.
03
BENEFITS
The Impact of AI in Healthcare
AI is redefining how healthcare systems make decisions, manage operations, and respond to global health challenges.
BENEFITS
The Impact of AI in Healthcare
AI is redefining how healthcare systems make decisions, manage operations, and respond to global health challenges.
Enhanced Decision-Making
AI analyzes complex medical data in real time, helping clinicians make faster and more accurate decisions.
Enhanced Decision-Making
AI analyzes complex medical data in real time, helping clinicians make faster and more accurate decisions.
Operational Efficiency & Sustainability
AI optimizes workflows and resources for smarter, sustainable healthcare.
20% Automation
60% Cost
BEFORE
AFTER
Operational Efficiency & Sustainability
AI optimizes workflows and resources for smarter, sustainable healthcare.
20% Automation
60% Cost
BEFORE
AFTER
Predictive & Preventive Health
AI predicts risks and prevents disease through intelligent data analysis.
Predictive & Preventive Health
AI predicts risks and prevents disease through intelligent data analysis.
TEAM
Our team brings together experts in AI, data science, and global health.
Driven by innovation and responsibility, we design systems that connect knowledge with real-world impact.
TEAM
Our team brings together experts in AI, data science, and global health.
Driven by innovation and responsibility, we design systems that connect knowledge with real-world impact.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.
Kazuaki Jindai
CEO ・ Co-founder ・ MD ・ DrPH
・ Physician-Entrepreneur specializing in infectious diseases and public health ・ Formerly worked with the World Health Organization (WHO) and Japan’s Ministry of Health, Labour and Welfare (MHLW) ・ Currently leads an AI-driven infectious disease data platform focused on surveillance and decision support ・ Board-certified in Internal Medicine, Infectious Diseases, and Preventive Medicine (U.S.), and Internal Medicine (Japan)
Hiroki Saito
Lead Medical Expert ・ MD ・ PhD ・ MPH
・ Physician specializing in infectious diseases and critical care, with clinical and public health experience in Japan, North America, Europe, and Africa ・ Served in Uganda as a JICA Japan Overseas Cooperation Volunteer ・ Earned a Master of Public Health (MPH) in the United States (Boston/California) ・ Board-certified in Internal Medicine and Infectious Diseases ・ Worked in the IDES program at Japan’s Ministry of Health, focusing on emerging and re-emerging infections, AMR, and quarantine operations ・ Served at the WHO Headquarters (IPC Global Unit), contributing to global sepsis and infection prevention initiatives ・ Completed a PhD at the University of Geneva, Institute of Global Health, conducting research on hand hygiene and infection control in Japan and Uganda ・ Member of the REMAP-CAP International Trial Steering Committee
Hee-Jin Kim
CTO ・ Co-founder
・ Founded and managed companies in the console and mobile gaming industry. ・ Founded and managed companies in the e-commerce industry. ・ Expert in AI system infrastructure and software development. ・ Certified Professional by ADaSci (International Association of Data Scientists). ・ Active in academic, research, and development activities at major AI conferences such as AAAI, IJCAI, ACL, and ICML.
ChelHo Shin
COO ・ Co-founder
・ Graduated from Waseda University Graduate School with a Master’s degree in International Politics. ・ Served as CEO and Co-Founder of JC Global (Japan), an online gaming service company. ・ Venture investment expert with over 16 years of experience in South Korea, having invested in more than 80 companies across diverse sectors. ・ Achieved 38 successful exits and currently manages investments in over 35 active portfolio companies.
Teppei Sakano
Director ・ Founder
・ Serial Entrepreneur ・ Visiting Professor at Tohoku University, Nagoya University, and Tokyo Medical and Dental University ・ Engaged in various public research and development projects on infectious disease control ・ President & CEO, GENARK Inc. ・ Director, PENTAS Inc. ・ Board Member, Japan Medical Venture Association (JMVA) ・ Councilor, National Institution for Youth Education (NIYE) ・ Visiting Professor, Tokyo Medical and Dental University / Nagoya University / Tohoku University ・ Research Fellow, Jikei University School of Medicine / Jichi Medical University ・ Board Member, Asia Cancer Forum (UICC)
Yuka Moriya
Co-founder
・ Engaged in procurement management at one of Japan’s largest general electronics group–affiliated procurement companies. ・ Entered the venture capital industry in 2014, handling fund formation, middle- and back-office operations, startup support, and community development. ・ Joined the founding of CartaNova in 2025. ・ Currently responsible for business development and fundraising across the GENARK Group, as well as in-house startup investment activities.